Immediate oral, immediate topical or delayed oral antibiotics for acute otitis media with discharge: the Runny Ear STudy (REST)

The University Of Bristol0 sites22 target enrollmentApril 24, 2018

Overview

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32493407/ protocol (added 06/01/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34816795/ (added 25/11/2021)

Registry

who.int

Start Date

April 24, 2018

End Date

June 30, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

The University Of Bristol

•1\. Children aged \=12 months to \<16 years
•2\. Presenting with recent onset (\=7 days) unilateral AOM with recent onset (\=7 days) otorrhoea currently visible (or seen by parent/carer \=24 hours)
•3\. Child attending with parent/carer who is legally able to give consent in person or parent able to give verbal consent via telephone call
•4\. Parent/carer willing and able to administer ear drops
•5\. Parent/carer willing, able and available to complete the daily SRQ and received regular telephone calls from the study team

•Current exclusion criteria as of 04/12/2018:
•1\. Symptoms/signs suggestive of bilateral AOM/AOMd
•2\. Child has symptoms/signs suggestive of serious illness and/or complications e.g. mastoiditis and/or requires immediate hospitalisation
•3\. Child requires immediate oral antibiotics (e.g. for another infection or AOMd considered severe);
•4\. As per NICE guidelines13, child at high risk of serious complications:
•4\.1\. Significant immunosuppression
•4\.2\. Heart, lung, renal, liver or neuromuscular disease (defined as requiring ongoing inpatient or outpatient care from specialist teams) co morbidities
•4\.3\. Trisomy 21 (Down’s Syndrome), Cystic Fibrosis or craniofacial malformation such as cleft palate (these children are known to be at higher risk of AOM)
•5\. Grommet (ventilation tube) in situ in the otorrhoea ear
•6\. Currently on oral (for a respiratory tract infection) or topical (in the affected ear) antibiotics